07:48 AM EDT, 05/10/2024 (MT Newswires) -- ProKidney ( PROK ) reported a Q1 net loss Friday of $0.16 per diluted share, unchanged from a year earlier.

Two analysts polled by Capital IQ had forecast a Q1 GAAP loss of $0.35 per share.

As expected, no revenue for the quarter ended March 31 was reported.

As of March 31, the company had $329 million in cash, cash equivalents and marketable securities, which it said was sufficient to fund operations into Q4 2025.